NCT05858138Completed
To Explore the Effectiveness of Jing-Si Herbal Tea Against Non-alcoholic Fatty Liver Disease
Source: ClinicalTrials.gov · Last updated 9 Sept 2025
Brief summary (registry, in English)
The aim of this study is to explore the effectiveness of Jing-Si Herbal Tea on improving the Non-alcoholic fatty liver disease patients
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 108 (actual)
- First submitted
- 26 Apr 2023
- Start date
- 3 May 2022
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Taichung Tzu Chi Hospital
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT05858138
What you commit to
- Study type: Interventional
- Participants enrolled: 108
- From 3 May 2022 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other related liver diseases will affect the study which evaluated by physicians
Other
- Do not sign the Informed consent
- Women of potential pregnancy or pregnant women
Who the study is looking for
- Sign the Informed consent
- Age between 20-70
- Diagnosis for moderated NAFLD
- Liver disease without hepatic decompensation
- HbA1c \< = 8.0 %
Age in the registry: 20 years to 70 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Taichung Tzu Chi Hospital Coordinator of this site? Confirm its status | Taichung | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.